Dais Craig 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Nov 14, 2023
Insider Transaction Report
Form 4
Dais Craig
Chief Financial Officer
Transactions
- Award
Common Stock
2023-11-10+973,633→ 973,633 total
Footnotes (1)
- [F1]Shares of stock vest in two tranches: 50% vest upon the date of the grant and the remaining 50% shall vest upon the one-year anniversary of the grant date, subject to Mr. Dais' continued employment with the Company.